Dynamics of HBV cccDNA expression and transcription in different cell growth phase

Journal of Biomedical Science

Chungming Chang⁵  Yu-Chi Chou³  King-Song Jeng³  Cheng-po Hu¹  Chien-Chiao Huang⁵  Kuen-Nan Tsai⁴  Yi-Chieh Wu⁵  Mong-Liang Chen²  Chin-Liew Chong⁵ 

[1] Department of Life Science, Tunghai University, 181, Sec.3, Taichung Port Road, Taichung, 40704, Taiwan;Center for Molecular Medicine, China Medical University and Hospital, 2, Yude Road, Taichung, 40447, Taiwan;Institute of Molecular Biology, Academia Sinica, 128, Sec. 2, Academia Road, Nankang, Taipei, 115, Taiwan;Institute of Molecular Medicine, National Tsing Hua University, 101, Sec.2, Kuang-Fu Road, Hsinchu, 30013, Taiwan;Institute of Molecular and Genomic Medicine, National Health Research Institutes, 35, Keyan Road, Zhunan Town, Miaoli, 350, Taiwan

关键词: growth confluency;    cell proliferation;    viral replication;    cccDNA;    HBV;   

Others  :  828712
DOI  :  10.1186/1423-0127-18-96

 received in 2011-11-18, accepted in 2011-12-30,  发布年份 2011

【 摘 要 】

Background

The covalently closed-circular DNA (cccDNA) of hepatitis B virus (HBV) is associated with viral persistence in HBV-infected hepatocytes. However, the regulation of cccDNA and its transcription in the host cells at different growth stages is not well understood.

Methods

We took advantages of a stably HBV-producing cell line, 1.3ES2, and examine the dynamic changes of HBV cccDNA, viral transcripts, and viral replication intermediates in different cellular growth stages.

Results

In this study, we showed that cccDNA increased suddenly in the initial proliferation phase of cell growth, probably attributable to its nuclear replenishment by intracellular nucleocapsids. The amount of cccDNA then decreased dramatically in the cells during their exponential proliferation similar to the loss of extrachromosomal plasmid DNA during cell division, after which it accumulated gradually while the host cells grew to confluency. We found that cccDNA was reduced in dividing cells and could be removed when proliferating cells were subjected to long term of lamivudine (3TC) treatment. The amounts of viral replicative intermediates were rapidly reduced in these proliferating cells and were significantly increased after cells reaching confluency. The expression levels of viral transcripts were increased in parallel with the elevated expression of hepatic transcription factors (HNF4α, CEBPα, PPARα, etc.) during cell growth confluency. The HBV transcripts were transcribed from both integrated viral genome and cccDNA, however the transcriptional abilities of cccDNA was less efficient then that from integrated viral genome in all cell growth stages. We also noted increases in the accumulation of intracellular viral particles and the secretion of mature virions as the cells reached confluency and ceased to grow.

Conclusions

Based on the dynamics of HBV replication, we propose that HBV replication is modulated differently in the different stages of cell growth, and can be divided into three phases (initial proliferation phase, exponential proliferation phase and growth confluency phase) according to the cell growth curve. The regulation of cccDNA in different cell growth phase and its importance regarding HBV replication are discussed.

【 授权许可】

   
2011 Chong et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Kao JH, Chen DS: Global control of hepatitis B virus infection. Lancet Infect Dis 2002, 2:395-403.
• [2]Dienstag JL: Hepatitis B virus infection. N Engl J Med 2008, 359:1486-1500.
• [3]Tuttleman JS, Pourcel C, Summers J: Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 1986, 47:451-460.
• [4]Sells MA, Zelent AZ, Shvartsman M, Acs G: Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J Virol 1988, 62:2836-2844.
• [5]Seeger C, Mason WS: Hepatitis B virus biology. Microbiol Mol Biol Rev 2000, 64:51-68.
• [6]Wu TT, Coates L, Aldrich CE, Summers J, Mason WS: In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Virology 1990, 175:255-261.
• [7]Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M: A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995, 333:1657-1661.
• [8]Nowak MA, Bonhoeffer S, Hill AM, Boehme R, Thomas HC, McDade H: Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci USA 1996, 93:4398-4402.
• [9]Abdelhamed AM, Kelley CM, Miller TG, Furman PA, Isom HC: Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment. J Virol 2002, 76:8148-8160.
• [10]Zhu Y, Yamamoto T, Cullen J, Saputelli J, Aldrich CE, Miller DS, Litwin S, Furman PA, Jilbert AR, Mason WS: Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J Virol 2001, 75:311-322.
• [11]Addison WR, Walters KA, Wong WW, Wilson JS, Madej D, Jewell LD, Tyrrell DL: Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication. J Virol 2002, 76:6356-6363.
• [12]Wieland SF, Spangenberg HC, Thimme R, Purcell RH, Chisari FV: Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees. Proc Natl Acad Sci USA 2004, 101:2129-2134.
• [13]Chou YC, Chen ML, Hu CP, Chen YL, Chong CL, Tsai YL, Liu TL, Jeng KS, Chang C: Transforming growth factor-beta1 suppresses hepatitis B virus replication primarily through transcriptional inhibition of pregenomic RNA. Hepatology 2007, 46:672-681.
• [14]Kuo TM, Hu CP, Chen YL, Hong MH, Jeng KS, Liang CC, Chen ML, Chang C: HBV replication is significantly reduced by IL-6. J Biomed Sci 2009, 16:41.
• [15]Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, Dandri M: Control of cccDNA function in hepatitis B virus infection. J Hepatol 2009, 51:581-592.
• [16]Lutgehetmann M, Volz T, Kopke A, Broja T, Tigges E, Lohse AW, Fuchs E, Murray JM, Petersen J, Dandri M: In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice. Hepatology 52:16-24.
• [17]Lugassy C, Bernuau J, Thiers V, Krosgaard K, Degott C, Wantzin P, Schalm SW, Rueff B, Benhamou JP, Tiollais P, et al.: Sequences of hepatitis B virus DNA in the serum and liver of patients with acute benign and fulminant hepatitis. J Infect Dis 1987, 155:64-71.
• [18]Hsu HY, Chang MH, Hsieh KH, Lee CY, Lin HH, Hwang LH, Chen PJ, Chen DS: Cellular immune response to HBcAg in mother-to-infant transmission of hepatitis B virus. Hepatology 1992, 15:770-776.
• [19]Gruppuso PA, Bienieki TC, Faris RA: The relationship between differentiation and proliferation in late gestation fetal rat hepatocytes. Pediatr Res 1999, 46:14-19.
• [20]Sureau C, Romet-Lemonne JL, Mullins JI, Essex M: Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell 1986, 47:37-47.
• [21]Huang YQ, Wang LW, Yan SN, Gong ZJ: Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells. Hepatobiliary Pancreat Dis Int 2004, 3:543-547.
• [22]Ozer A, Khaoustov VI, Mearns M, Lewis DE, Genta RM, Darlington GJ, Yoffe B: Effect of hepatocyte proliferation and cellular DNA synthesis on hepatitis B virus replication. Gastroenterology 1996, 110:1519-1528.
• [23]Chou YC, Jeng KS, Chen ML, Liu HH, Liu TL, Chen YL, Liu YC, Hu CP, Chang C: Evaluation of transcriptional efficiency of hepatitis B virus covalently closed circular DNA by reverse transcription-PCR combined with the restriction enzyme digestion method. J Virol 2005, 79:1813-1823.
• [24]Calvert J, Summers J: Two regions of an avian hepadnavirus RNA pregenome are required in cis for encapsidation. J Virol 1994, 68:2084-2090.
• [25]Biermer M, Puro R, Schneider RJ: Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB. J Virol 2003, 77:4033-4042.
• [26]Moolla N, Kew M, Arbuthnot P: Regulatory elements of hepatitis B virus transcription. J Viral Hepat 2002, 9:323-331.
• [27]Schrem H, Klempnauer J, Borlak J: Liver-enriched transcription factors in liver function and development. Part II: the C/EBPs and D site-binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regeneration, apoptosis, and liver-specific gene regulation. Pharmacol Rev 2004, 56:291-330.
• [28]Ishiyama T, Kano J, Minami Y, Iijima T, Morishita Y, Noguchi M: Expression of HNFs and C/EBP alpha is correlated with immunocytochemical differentiation of cell lines derived from human hepatocellular carcinomas, hepatoblastomas and immortalized hepatocytes. Cancer Sci 2003, 94:757-763.
• [29]Cereghini S: Liver-enriched transcription factors and hepatocyte differentiation. FASEB J 1996, 10:267-282.
• [30]Schrem H, Klempnauer J, Borlak J: Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression. Pharmacol Rev 2002, 54:129-158.
• [31]Yoon JH, Lee HS, Kim TH, Woo GH, Kim CY: Augmentation of urea-synthetic capacity by inhibition of nitric oxide synthesis in butyrate-induced differentiated human hepatocytes. FEBS Lett 2000, 474:175-178.
• [32]Felsher DW, Bishop JM: Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell 1999, 4:199-207.
• [33]de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB: Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 2003, 370:737-749.
• [34]Yeh CT, Chiu HT, Chu CM, Liaw YF: G1 phase dependent nuclear localization of relaxed-circular hepatitis B virus DNA and aphidicolin-induced accumulation of covalently closed circular DNA. J Med Virol 1998, 55:42-50.
• [35]Turin F, Borel C, Benchaib M, Kay A, Jamard C, Guguen-Guillouzo C, Trepo C, Hantz O: n-Butyrate, a cell cycle blocker, inhibits early amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of duck hepatocytes. J Virol 1996, 70:2691-2696.
• [36]Tang H, McLachlan A: Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism. Proc Natl Acad Sci USA 2001, 98:1841-1846.
• [37]Choi BH, Park GT, Rho HM: Interaction of hepatitis B viral X protein and CCAAT/enhancer-binding protein alpha synergistically activates the hepatitis B viral enhancer II/pregenomic promoter. J Biol Chem 1999, 274:2858-2865.
• [38]Ishida H, Ueda K, Ohkawa K, Kanazawa Y, Hosui A, Nakanishi F, Mita E, Kasahara A, Sasaki Y, Hori M, Hayashi N: Identification of multiple transcription factors, HLF, FTF, and E4BP4, controlling hepatitis B virus enhancer II. J Virol 2000, 74:1241-1251.
• [39]Galle PR, Schlicht HJ, Kuhn C, Schaller H: Replication of duck hepatitis B virus in primary duck hepatocytes and its dependence on the state of differentiation of the host cell. Hepatology 1989, 10:459-465.
• [40]Glebe D, Berting A, Broehl S, Naumann H, Schuster R, Fiedler N, Tolle TK, Nitsche S, Seifer M, Gerlich WH, Schaefer S: Optimised conditions for the production of hepatitis B virus from cell culture. Intervirology 2001, 44:370-378.
• [41]Gao W, Hu J: Formation of hepatitis B virus covalently closed circular DNA: removal of genome-linked protein. J Virol 2007, 81:6164-6174.
• [42]Ganusov VV, Brilkov AV: Estimating the instability parameters of plasmid-bearing cells. I. Chemostat culture. J Theor Biol 2002, 219:193-205.
• [43]Jang JH, Rives CB, Shea LD: Plasmid delivery in vivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection. Mol Ther 2005, 12:475-483.
• [44]Wong DK, Yuen MF, Poon RT, Yuen JC, Fung J, Lai CL: Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma. J Hepatol 2006, 45:553-559.
• [45]Civitico GM, Locarnini SA: The half-life of duck hepatitis B virus supercoiled DNA in congenitally infected primary hepatocyte cultures. Virology 1994, 203:81-89.